Après Venture

Transforming Clinical Research – Insights from Rauno Oja, CEO of EGeen International Corporation In this episode, Rauno Oja, CEO of EGeen International Corporation, shares his distinctive perspective on the pharmaceutical and clinical research industry. With a background in business administration rather than medicine, Rauno entered the sector immediately after graduation and has since built one o...

Summary In this episode of the Après Venture Podcast, host Finith Jernigan sits down with Marc Teitelbaum, co-founder of Prognostic Optimization Group (POG AI). Marc shares his unconventional path from EMT and premed to biotech consulting, a PhD in regenerative medicine, drug development startups, and ultimately founding POG AI after a frustrating doctor’s visit wait time. He explains how POG AI u...

This episode of the Après Venture Podcast delves into the intricacies of chemical reactions, focusing on selectivity and the challenges faced in chemical synthesis. The discussion highlights innovative approaches in chemical research, including the use of deuterated solvents and NMR techniques to achieve better outcomes in reactions. The conversation also touches on future directions in the field...

In this episode of the podcast, we dive deep into the innovative world of Single Time Microneedles with CEO Jasdeep Singh. As healthcare faces numerous challenges, from patient compliance to the complexities of vaccine distribution, this technology emerges as a game changer. Join us as we explore how microneedles are set to transform community health and the pharmaceutical landscape.

What if we could watch a human cell in real time—without dyes, without fixation, without killing it—every 4 minutes for days? That’s exactly what founder Parmita Mishra is building at Precigenetics. In this episode of the Biocatalyst AI Podcast, Parmita sits down with host Finith Jernigan to unpack: How a near-fatal allergy attack in her freshman dorm at Penn forced her to pivot from wet-lab biolo...

The conversation focuses on the commitment to improving healthcare access in Africa, particularly through the manufacturing of monoclonal antibodies. The speaker emphasizes the importance of leveraging expertise gained in the West to benefit African patients and highlights the upcoming capabilities in producing essential medicines on the continent.

In this episode of the Apres Venture Podcast Presented by Finith Capital, host Finith Jernigan chats with Dr. Jamie Rice, Head of Discovery Biology at Covent Therapeutics. Dr. Rice shares his journey from running a construction business to earning a PhD in immunology, working on cutting-edge immuno-oncology at Harvard, and now leading autoimmune disease research. They dive into the shift from broa...

Why am I starting a podcast?